Per-Anders Abrahamsson (Former)
81 – 90 of 125
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2006
-
Mark
Advances in Biomarkers for Prostate Diseases
(2006) p.85-85
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Interview with Professor Per-Anders Abrahamson: Angiogenesis and renal cell carcinoma
- Contribution to journal › Debate/Note/Editorial
-
Mark
The Prostate Cancer Prevention Trial and its implications for clinical practice: A European consensus
- Contribution to journal › Article
- 2005
-
Mark
The 5alpha-Reductase Type II A49T and V89L High-Activity Allelic Variants are More Common in Men with Prostate Cancer Compared with the General Population.
- Contribution to journal › Article
-
Mark
Neuroendocrine differentiation in prostate cancer: Implications for new treatment modalities
- Contribution to journal › Scientific review
-
Mark
Expression of Serotonin Receptors 2B and 4 in Human Prostate Cancer Tissue and Effects of Their Antagonists on Prostate Cancer Cell Lines.
- Contribution to journal › Article
-
Mark
Prognostic value of serum markers for prostate cancer
- Contribution to journal › Article
-
Mark
Risks and benefits of hormonal manipulation as monotherapy or adjuvant treatment in localised prostate cancer.
- Contribution to journal › Scientific review
- 2004
-
Mark
Androgen receptor CAG repeat length correlates with semen PSA levels in adolescence.
- Contribution to journal › Article
-
Mark
Long-term testosterone stimulation induces hyperplasia in the guinea-pig prostate.
- Contribution to journal › Article
